How items are ranked
- Evidence level: regulatory action and guidelines, then phase 3 RCT, meta-analysis, prospective, retrospective, commentary.
- Source tier: peer-reviewed journal and regulator first, then society and trade press.
- Practice impact: whether it changes what a provider can offer this month.
Ranking is rule-based. No sponsor or author pays for placement.
Editorial policy
UrologyWatch is a neutral aggregator. Summaries are original and link to the primary source; we do not reproduce abstracts or figures. A new edition is published every morning at about 5 AM ET; the time at the top of the page shows when the current edition was built.
Archive by date About UrologyWatch Urology History
Daily email
Not medical advice
Content is for general information. Patients should discuss any treatment decision with their own urology provider.
Privacy Terms of use
© 2026 UrologyWatch.com Contact: [email protected]